Best Peptides for Brain Health & Cognition

Nootropic peptides studied for cognitive enhancement, neuroprotection, and mood support

Cognitive peptides represent a diverse class of compounds studied for their effects on brain function — from memory and focus to neuroprotection and mood regulation. Many originate from Russian pharmaceutical research (Selank, Semax) while others emerged from Western neuroscience labs.

The mechanisms vary widely: some modulate BDNF and NGF expression, others affect GABA signaling, and newer compounds like Dihexa target hepatocyte growth factor pathways. The evidence base ranges from robust clinical data to early preclinical studies.

Brain Health & Cognition Peptides (8)

Semax

Cognition, Mood & Neuroprotection

Semax is a synthetic peptide derived from a brain hormone fragment (ACTH 4-10), developed in Russia for brain-protective and cognitive-enhancing purposes. Research focuses on stroke recovery, cognitive function, and brain growth factor support.

Selank

Cognition, Mood & Neuroprotection

Selank is a synthetic seven-amino-acid peptide derived from the immune protein tuftsin, developed in Russia. Research shows it has both immune-supporting and anti-anxiety properties without causing sedation or dependence.

Dihexa

Cognition, Mood & Neuroprotection

Dihexa is a synthetic six-amino-acid peptide related to angiotensin IV with strong cognitive-enhancing properties. It has been proposed to be millions of times more potent than natural brain growth factors at promoting nerve cell connections. Research focuses on cognitive enhancement and neurodegenerative diseases.

DSIP (Delta Sleep Inducing Peptide)

Cognition, Mood & Neuroprotection

DSIP (Delta Sleep Inducing Peptide) is a naturally occurring brain peptide first isolated from rabbit brain tissue. Research focuses on sleep promotion, stress reduction, and hormone regulation. It shows complex effects that vary depending on the context.

Cerebrolysin

Cognition, Mood & Neuroprotection

Cerebrolysin is a preparation derived from pig brain tissue containing small brain-protective peptides and amino acids. It is approved in many countries (but not the United States) for stroke, traumatic brain injury, and dementia. It is one of the most extensively studied brain peptide formulations.

PE-22-28

Cognition, Mood & Neuroprotection

PE-22-28 is a synthetic seven-amino-acid peptide designed to block a specific potassium channel (TREK-1) in the brain. Research in animal models focuses on antidepressant-like effects and cognitive enhancement through brain growth factor support and increased brain cell adaptability.

Pinealon

Cognition, Mood & Neuroprotection

Pinealon is a synthetic three-amino-acid peptide that may help regulate pineal gland and central nervous system function. Developed in Russia, research focuses on sleep regulation, brain cell protection, and cognitive function in aging.

Cortagen

Cognition, Mood & Neuroprotection

Cortagen is a synthetic four-amino-acid peptide that may help regulate brain cortex function. Developed at the St. Petersburg Institute of Bioregulation and Gerontology, research focuses on supporting cognitive function in aging and protecting brain cells.

Frequently Asked Questions

Semax and Selank are the most extensively researched nootropic peptides, with decades of clinical use in Russia. Semax has been approved in Russia since 2011 for cognitive and neurological conditions. Cerebrolysin also has extensive clinical data from European trials.

Selank and Semax have favorable safety profiles in published studies, with minimal reported side effects. They are administered intranasally, avoiding injection. However, newer compounds like Dihexa have very limited human safety data and should be approached with caution.

Many cognitive peptides are designed to cross the blood-brain barrier or are administered intranasally to bypass it. Semax and Selank are typically given as nasal sprays. Dihexa was specifically designed for oral bioavailability with CNS penetration.

Semax is an ACTH(4-10) analog that enhances focus, motivation, and cognitive clarity by upregulating BDNF and modulating dopaminergic/serotonergic signaling. Selank is a tuftsin analog that reduces anxiety and promotes calm focus through GABAergic modulation and serotonin pathway effects. Simply put: Semax is the stimulating nootropic, Selank is the anxiolytic stabilizer. They are sometimes used together.

Both have favorable safety profiles based on decades of clinical use in Russia. Semax may cause nasal irritation, mild headaches, or sleep disturbances if taken too late in the day. Selank side effects are minimal, with occasional mild taste irritation. Neither shows evidence of tolerance, dependence, or withdrawal in published research.

Acute effects from Semax (improved focus, mental clarity) can be noticed within minutes to hours of intranasal administration. Selank's anxiolytic effects typically become apparent within 1-2 weeks, with more robust nootropic benefits emerging at 4-6 weeks of consistent use. Dihexa and other experimental compounds have less defined timelines due to limited human data.

No. Neither Semax nor Selank is FDA-approved in the U.S. Both are approved and clinically used in Russia, where Semax has been registered since 2011 for cognitive and neurological conditions. Cerebrolysin has clinical data from European trials but is also not FDA-approved. These peptides are available in the U.S. only as research compounds.

Related Categories